Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1057)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (19)
  8. Conference Paper (15)
  9. Correspondence (12)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2698)
  2. Department of Medicine (2698)
  3. Hematologic Malignancies, Division of (2698)
  4. Population Sciences Research Program (744)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (782)
  2. Steven Horwitz (666)
  3. Maria Palomba (445)
  4. Ariela Noy (371)
  5. David Straus (360)
  6. Alison Moskowitz (358)

More People

Years
  1. 2025 (45)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (83)
  5. British Journal of Haematology (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2698)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naive patients >= 65 years with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Dubowy, R.; O'Brien, S.; Lamanna, N.; Kipps, T.; Flinn, I.; Zelenetz, A.; Burger, J.; Holes, L.; Cho, Y.; Coutre, S.
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Health-related quality of life impact of idelalisib in patients with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results
    Meeting Abstract

    Munir, T.; Hillmen, P.; Eradat, H.; Ghia, P.; O'Brien, S.; Furman, R.; Coutre, S.; Sharman, J.; Cheson, B.; Pagel, J.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Second interim analysis of a phase 3 study of idelalisib plus rituximab (R) for relapsed chronic lymphocytic leukaemia (CLL): Efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors
    Meeting Abstract

    Munir, T.; Hillmen, P.; Sharman, J.; Coutre, S.; Furman, R.; Cheson, B.; Pagel, J.; Barrientos, J.; Zelenetz, A.; Kipps, T.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma
    Journal Article

    Mussetti, A.; Kumar, A.; Dahi, P. B.; Perales, M. A.; Sauter, C. S.
    Blood Reviews (2015)

    Fulltext@MSK | Save
  • Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
    Journal Article

    Barta, S. K.; Samuel, M. S.; Xue, X.; Wang, D.; Lee, J. Y.; Mounier, N.; Ribera, J. M.; Spina, M.; Tirelli, U.; Weiss, R.; more...
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Emerging drugs for diffuse large B-cell lymphoma
    Journal Article

    Mondello, P.; Younes, A.
    Expert Review of Anticancer Therapy (2015)

    Fulltext@MSK | Save
  • FDG PET/CT imaging as a biomarker in lymphoma
    Journal Article

    Meignan, M.; Itti, E.; Gallamini, A.; Younes, A.
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save
  • Are we ready to predict late effects? A systematic review of clinically useful prediction models
    Journal Article

    Salz, T.; Baxi, S. S.; Raghunathan, N.; Onstad, E. E.; Freedman, A. N.; Moskowitz, C. S.; Dalton, S. O.; Goodman, K. A.; Johansen, C.; Matasar, M. J.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project
    Journal Article

    Dabaja, B. S.; Vanderplas, A. M.; Crosby-Thompson, A. L.; Abel, G. A.; Czuczman, M. S.; Friedberg, J. W.; Gordon, L. I.; Kaminski, M.; Niland, J.; Millenson, M.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • Ibrutinib in previously treated Waldenström's macroglobulinemia
    Journal Article

    Treon, S. P.; Tripsas, C. K.; Meid, K.; Warren, D.; Varma, G.; Green, R. ; Argyropoulos, K. V.; Yang, G.; Cao, Y.; Xu, L.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save